Hello and welcome back to The Kable. We hope you have a light last day of the week planned? No? Neither does the life sciences industry. Today’s Kable is full to the brim with news of FDA approvals, frameworks from the WHO, and a look back at the eventful life sciences week that was.
First, health tech in India gets a boost as Medtronic announces a ₹3000…



